ICS develops novel solutions that offer full capture and protection from embolic material released during left-sided heart procedures.
Innovative Cardiovascular Solutions has raised $655K in total funding. The most recent round was Debt Financing. The last funding was announced in January 2022.
Innovative Cardiovascular Solutions is headquartered in Grand Rapids, United States.
ICS develops novel solutions that offer full capture and protection from embolic material released during left-sided heart procedures.
Innovative Cardiovascular Solutions is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Innovative Cardiovascular Solutions — Funding & Investors." VCBacked, January 3, 2022, https://www.vcbacked.co/company/innovative-cardiovascular-solutions. Accessed August 14, 2026.
VCBacked. (2022). Innovative Cardiovascular Solutions — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/innovative-cardiovascular-solutions
{{cite web |title=Innovative Cardiovascular Solutions — Funding & Investors |url=https://www.vcbacked.co/company/innovative-cardiovascular-solutions |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated